Tianhong Shengjie Medical Receives Fourth Class III NMPA Approval in 2026 for V-Scoring™ Peripheral Scoring Balloon Catheter
Venmedtech
Peripheral Vascular Field Product R&D and Manufacturer
Recently, enterprises within MedparkSuzhou Venmed Technology Co., Ltd.（with(hereinafter referred to as "Venmedtech Medical")）Another piece of good news: its independently developed V-ScoringTMPeripheral Vascular Scoring Balloon Dilatation Catheter Successfully Obtains Class III Medical Device Registration Certificate Approved by the National Medical Products Administration (NMPA), Registration Certificate No.: Guo Xie Zhu Zhun 20263031053.This is also the fourth [certificate] obtained by Venmedtech this yearClass IIIMedical Device Registration Certificate, the product ecosystem encompassing the entire process of minimally invasive interventional therapy is rapidly taking shape.
V-ScoringTMPeripheral Scoring Balloon Dilatation Catheter
In the era of endovascular therapy, vessel preparation has become the cornerstone determining long-term efficacy. The management of calcified lesions is a highly challenging diagnostic and therapeutic dilemma in lower extremity arteriosclerosis obliterans. Venmedtech introduces V-ScoringTMPeripheral Scoring Balloon Dilatation Catheter: Targeted Solutions for Clinical Challenges.
Principles of Innovation
Oriented cracking of calcified rings via guidewire to release luminal stress and create controlled, directional plaque injury.
Hardcore Design: Safeguarding Surgical Safety and Precision
V-ScoringTMEquipped with triangular wedge-shaped 360° spiral nitinol scoring wires, the integrated molding process eliminates the risk of scoring wire detachment. Full expansion is achieved at a low pressure of 8 atm, and the anchoring effect prevents balloon slippage, thereby eliminating the "watermelon seed effect."
Minimal Incision, Superior Vascular Access
V-ScoringTMIt can create regular longitudinal micro-incisions, significantly reducing flow-limiting dissections and elastic recoil, resulting in superior immediate luminal gain and lower residual stenosis.
Widely Applied, Multi-Functional Device
The product can independently treat lesions or serve as a pretreatment device for drug-coated balloons (DCB), regularizing the vessel wall to promote uniform drug penetration. It is suitable for complex lesions such as calcified occlusions, in-stent restenosis, and arteriovenous fistula stenosis.
Venmedtech, established in 2016 and located in the Accelerator Building of the Jiangsu Medical Device Technology Industrial Park, is a leading enterprise in China's venous intervention sector and is striving to build a globally leading innovation platform for peripheral interventional devices. Earlier this year, the company obtained three Class III medical device registration certificates within a single month.With the latest new product gaining approval, the cumulative number of approved products within the year has reached four.; In May, the company also successfully completed an equity financing round worth tens of millions of yuan. The concurrent issuance of multiple certificates and capital injection fully demonstrate Venmedtech’s outstanding independent R&D capabilities and broad market prospects, injecting strong momentum into the company’s continued expansion in both domestic and international markets.
